Immune

Developing, funding and conducting clinical trials in immune tolerance

Home

For people with T1D who were previously enrolled in an ITN clinical study.

 

T1DES is not currently enrolling participants.

  • Home
  • About Type 1 Diabetes
  • About T1DES
  • Am I Eligible?
  • Study Locations

Other T1D Trials

Additional Type 1 Diabetes Research Studies Being Conducted by the ITN

EXTEND Preserving Beta-Cell Function with Tocilizumab in New-Onset Type 1 Diabetes

The EXTEND study is a clinical research study testing whether tocilizumab (Actemra ®) can protect remaining beta cells in individuals recently diagnosed with type 1 diabetes and extend the ability to naturally produce insulin.

For more information about the ITN and other clinical trials, please visit immunetolerance.org.

  • About ITN
  • More ITN Trials
  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials
NIH   

T1DES is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded), with support from JDRF.

  • Home
  • About Type 1 Diabetes
  • About T1DES
  • Am I Eligible?
  • Study Locations
  • About ITN
  • More ITN Trials
  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials